Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...
As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections. Use of these medications ...
What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...
and creating investment and partnering opportunities with the private sector.” Even some Republicans have sounded the alarm ...
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
225 Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation follows ...
"FDA grants orphan drug status to Arbor Biotechnologies’ PH1" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...
BERLIN, Feb. 6, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat ...
The duo was booked under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. The BKC police, on Dec 27, received a tip-off that Riyaz Telli, who indulges in drug peddling, was likely to ...
BERLIN, Feb. 6, 2025 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, ...
Subscribe for FREE The process of using an existing drug for a purpose other than its initial intent is called drug repurposing. Many diseases may appear very different—in symptoms, prognosis, or even ...
Ariceum Therapeutics, a private biotech company based in Berlin, has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its proprietary ...